Ignite Creation Date:
2025-12-24 @ 6:47 PM
Ignite Modification Date:
2026-01-20 @ 11:16 PM
Study NCT ID:
NCT03873857
Status:
COMPLETED
Last Update Posted:
2023-09-01
First Post:
2019-03-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Assess Effectiveness of Venclexta (Venetoclax) in Patients With Relapse or Refractory Chronic Lymphocytic Leukemia in Routine Clinical Practice in Russian Federation
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-02-25
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-09-12
Completion Date Type:
ACTUAL
First Submit Date:
2019-03-12
First Submit QC Date:
None
Study First Post Date:
2019-03-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-30
Last Update Post Date:
2023-09-01
Last Update Post Date Type:
ACTUAL